Inhibitory effect of jaceosidin isolated from Artemisia argyi on the function of E6 and E7 oncoproteins of HPV 16

被引:99
作者
Lee, HG
Yu, KA
Oh, WK
Baeg, TW
Oh, HC
Ahn, JS
Jang, WC
Kim, JW
Lim, JS
Choe, YK
Yoon, DY
机构
[1] Korea Res Inst Biosci & Biotechnol, Cell Biol Lab, Taejon 305600, South Korea
[2] Korea Res Inst Biosci & Biotechnol, Lab Cellular Signaling Modulator, Taejon 305600, South Korea
[3] DanKook Univ, Dept Chem, CheonAn 330714, South Korea
[4] DanKook Univ, Dept Lab Med, CheonAn 330714, South Korea
关键词
cervical cancer; HPV; E6; E7; Artermisia argyi; Jaceosidin;
D O I
10.1016/j.jep.2005.01.054
中图分类号
Q94 [植物学];
学科分类号
071001 [植物学];
摘要
Jaceosidin (4',5,7-trihydroxy-3',6-dimethoxyflavone) was isolated from Artemisia argyi as a putative oncogene inhibitor. Jaceosidin inhibited binding between oncoprotein E6 of the human papillomavirus and the p53 tumor suppressor protein. In addition, jaceosidin inhibited binding between the E7 oncoprotein and the Rb tumor suppressor protein, and also inhibited the function of HPV-16 harboring cervical cancer cells, including SiHa and CaSki. Collectively, jaceosidin inhibited the functions of the E6 and E7 oncoproteins of the human papillomavirus, suggesting that this compound might be used as a potential drug for the treatment of cervical cancers associated with the human papillomavirus. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:339 / 343
页数:5
相关论文
共 16 条
[1]
STRUCTURAL AND TRANSCRIPTIONAL ANALYSIS OF HUMAN PAPILLOMAVIRUS TYPE-16 SEQUENCES IN CERVICAL-CARCINOMA CELL-LINES [J].
BAKER, CC ;
PHELPS, WC ;
LINDGREN, V ;
BRAUN, MJ ;
GONDA, MA ;
HOWLEY, PM .
JOURNAL OF VIROLOGY, 1987, 61 (04) :962-971
[2]
Potential drugs against cervical cancer: Zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein [J].
Beerheide, W ;
Bernard, HU ;
Tan, YJ ;
Ganesan, A ;
Rice, WG ;
Ting, AE .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1211-1220
[3]
Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding [J].
Cho, YS ;
Cho, CW ;
Joung, O ;
Lee, KA ;
Park, SN ;
Yoon, DY .
ANTIVIRAL RESEARCH, 2000, 47 (03) :199-206
[4]
Cho YS, 2001, J BIOCHEM MOL BIOL, V34, P80
[5]
HUMAN PAPILLOMAVIRUS TYPE-16-E6 INCREASES THE DEGRADATION RATE OF P53 IN HUMAN KERATINOCYTES [J].
HUBBERT, NL ;
SEDMAN, SA ;
SCHILLER, JT .
JOURNAL OF VIROLOGY, 1992, 66 (10) :6237-6241
[6]
HUMAN PAPILLOMAVIRUS-16 E6 EXPRESSION DISRUPTS THE P53-MEDIATED CELLULAR-RESPONSE TO DNA DAMAGE [J].
KESSIS, TD ;
SLEBOS, RJ ;
NELSON, WG ;
KASTAN, MB ;
PLUNKETT, BS ;
HAN, SM ;
LORINCZ, AT ;
HEDRICK, L ;
CHO, KR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (09) :3988-3992
[7]
A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651
[8]
Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines [J].
Meissner, JD .
JOURNAL OF GENERAL VIROLOGY, 1999, 80 :1725-1733
[9]
Antimutagens in gaiyou (Artemisia argyi Levl. et Vant.) [J].
Nakasugi, T ;
Nakashima, M ;
Komai, K .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2000, 48 (08) :3256-3266
[10]
PAGANO M, 1992, ONCOGENE, V7, P1681